Global Cancer Biomarker Testing Market Size, Share, Trends, Growth factors, Top Key Players, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024

Global Cancer Biomarker Testing Market Size, Share, Trends, Growth factors, Top Key Players, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024

Global Cancer Biomarker Testing Market report offers Market Size, Dynamics, Regional Market Share, Top Key Players, Latest trends, Growth factors, Industry Stats, Historic Market, Business Intelligence, Business Research Reports, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024

The cancer biomarker test market is driven by rising prevalence of cancer worldwide. World Health Organization (WHO) stated that cancer is one of the leading causes of mortality and morbidity worldwide, with approximately 14 Mn new cases in 2012. The number of new cases is expected to rise about 70% over the coming 2 decades. In addition, increase in awareness in public and healthcare professionals regarding early diagnostic procedures, rise in government and NGO’s funding for oncology are expected to bolster the cancer biomarker testing market. Furthermore, the development of companion diagnostics and recent breakthrough in detection techniques such as proteomics, metabolomics, genomics and transcriptomics are further expected to boost the cancer biomarker test market. However, high cost for biomarker tests, low detection rates and regulatory policies are expected to hamper the cancer biomarker test market.

A sample of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/global-cancer-biomarker-testing-market/#ulp-4H8Z4LpNMLEuOnnx

Cancer biomarker testing market segmented based on type of cancer, application, bio molecule and end user
Based on type of cancer, cancer biomarker test market is segmented into
• Cervical cancer
• Lung Cancer
• Collateral Cancer
• Liver Cancer
• Prostate Cancer
• Breast Cancer
• Others

Based on application, cancer biomarker test market is segmented into
• Drug Discovery and Development
• Personalised Medicine
• Diagnosis
• Others

Based on end-user, cancer biomarker test market is segmented into
• Hospitals
• Cancer diagnostic Centres
• Research Institutes
• Others

To view TOC of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/global-cancer-biomarker-testing-market/#ulp-c654SbFYO64MsOhu

The global cancer biomarker test market is expected to grow with significant CAGR during forecast period. Market players are carrying out collaborations, partnerships, and acquisitions as key development strategies to enhance the market share. For instance, in March 2017, Foundation Medicine and Bristol-Myers Squibb entered collaboration to understand tumour profile and its microenvironment to predict patient’s response to cancer immunotherapy. Using Foundation Medicine’s foundation genomic profiling assay, the firm will look at tumour mutational burden and microsatellite instability in patients enrolled in clinical trials for Bristol-Myers Squibb (BMS) cancer drugs. For instance, in October 2016, Arquer Diagnostics Ltd. (Arquer), and University of Sunderland are collaborated to investigate noninvasive specimen preparation techniques that will facilitate the use of Arquer’s MCM5-ELISA test in a wide range of cancers. In April 2016, Stemcentrix acquired by AbbiVe along with its lead late stage biomarker rovalpituzumab tesirine (Rova-T), that helps to identify tumour cells.

Need more information about this report @
https://www.precisionbusinessinsights.com/market-reports/global-cancer-biomarker-testing-market/#ulp-14mlyhjMGhVjZqa3

Some of the players in cancer biomarker test market are Thermo Fisher Scientific (Affymetrix Inc.) (U.S.), Abbott Laboratories (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), AbbVie Inc. (U.S.), Arquer Diagnostics Ltd. (U.K.), Illumina, Inc. (U.S.), Qiagen (Germany), Agilent Technologies (U.S.), Merck & Co. Inc. (U.S.), Becton Dickinson and Company (U.S.), and Hologic Inc. (U.S.) to name a few.

About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.
Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI’s approachable strategies are to help clients to make key decisions for business growth.
Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights

Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: [email protected]
Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com